G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages

被引:44
作者
Thomas, GR
Costelloe, EA
Lunn, DP
Stacey, KJ
Delaney, SJ
Passey, R
McGlinn, EC
McMorran, BJ
Ahadizadeh, A
Geczy, CL
Wainwright, BJ
Hume, DA [1 ]
机构
[1] Univ Queensland, Ctr Cellular & Mol Biol, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Dept Microbiol & Biochem, St Lucia, Qld 4072, Australia
[3] Univ New S Wales, Sch Pathol, Cytokine Res Unit, Kensington, NSW 2033, Australia
关键词
D O I
10.4049/jimmunol.164.7.3870
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The major cause of death in cystic fibrosis (CF) is chronic lung disease associated with persistent infection by the bacterium, Pseudomonas aeruginosa, S100A8, an S-100 calcium-binding protein with chemotactic activity, is constitutively expressed in the lungs and serum of CF patients. Levels of S100A8 mRNA were found to be three to four times higher in the lungs of mice carrying the G551D mutation in CF transmembrane conductance regulator compared with littermate controls, Intravenous injection of bacterial LPS induced S100A8 mRNA in the lung to a greater extent in G551D mice than in wild-type littermates, Localization of S100A8 mRNA and protein in the lung indicate that it is a marker for neutrophil accumulation. Bone marrow-derived macrophages from G551D mice were shown to also exhibit hypersensitivity to LPS, measured by induction of TNF-alpha. These results provide evidence that the pathology of CF relates to abnormal regulation of the immune system.
引用
收藏
页码:3870 / 3877
页数:8
相关论文
共 45 条
  • [21] Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease
    Matsui, H
    Grubb, BR
    Tarran, R
    Randell, SH
    Gatzy, JT
    Davis, CW
    Boucher, RC
    [J]. CELL, 1998, 95 (07) : 1005 - 1015
  • [22] Reduced IL-10 secretion by CD4(+) T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR)
    Moss, RB
    Bocian, RC
    Hsu, YP
    Dong, YJ
    Kemna, M
    Wei, T
    Gardner, P
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (02) : 374 - 388
  • [23] Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis
    Noah, TL
    Black, HR
    Cheng, PW
    Wood, RE
    Leigh, MW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) : 638 - 647
  • [24] S100A8: emerging functions and regulation
    Passey, RJ
    Xu, K
    Hume, DA
    Geczy, CL
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) : 549 - 556
  • [25] Passey RJ, 1999, J IMMUNOL, V163, P2209
  • [26] EXPRESSION AND REGULATION OF TUMOR-NECROSIS-FACTOR IN MACROPHAGES FROM CYSTIC-FIBROSIS PATIENTS
    PFEFFER, KD
    HUECKSTEADT, TP
    HOIDAL, JR
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (05) : 511 - 519
  • [27] How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis
    Pier, GB
    Grout, M
    Zaidi, TS
    Goldberg, JB
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) : S175 - S182
  • [28] Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung
    Pier, GB
    Grout, M
    Zaidi, TS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12088 - 12093
  • [29] Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
    Pier, GB
    Grout, M
    Zaidi, TS
    Olsen, JC
    Johnson, LG
    Yankaskas, JR
    Goldberg, JB
    [J]. SCIENCE, 1996, 271 (5245) : 64 - 67
  • [30] INCREASED COEXPRESSION OF CFTR AND S100 CALCIUM-BINDING PROTEINS MRP8 AND MRP14 MESSENGER-RNAS IN CYSTIC-FIBROSIS HUMAN TRACHEAL GLAND-CELLS
    RENAUD, W
    MERTEN, M
    FIGARELLA, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) : 1518 - 1525